Purchase Order 36C26118P0026
Award Date 10/5/17
Potential Completion Date 10/26/17
Potential Value $83K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
King of Prussia, PA 19406, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award made by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a foreign-owned, for-profit pharmaceutical company, under the VA's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs. The contract is a delivery order for the emergency purchase of HAEGARDA, a C1 inhibitor treatment for hereditary angioedema, with a ceiling value of $86,377.78 and a completion date of October 18, 2019. This contract is not set aside. CSL Behring L.L.C....
- This is a federal contract award by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a foreign-owned, for-profit biotherapeutics company. The $83,607.60 firm fixed-price delivery order is for the supply of 3,000 units of the drug HAEGARDA to the James H. Quillen VA Medical Center and Nashville VA Medical Center. This award is made under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which has a ceiling value of...
- This is a delivery order awarded by the Veterans Integrated Service Network 8 (VISN 8), part of the U.S. Department of Veterans Affairs (VA), to CSL Behring L.L.C. The contract, which has a ceiling value of $87,207.54, is for the procurement of HAEGARDA, a C1 inhibitor medication used to treat hereditary angioedema. The delivery order was issued under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which has a larger ceiling value of...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to the prime contractor CSL Behring L.L.C., doing business as CSL Behring LLC, a global biotherapeutics company. The $108,668.56 firm fixed price delivery order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the General Services Administration. The order is for the Hereditary Angioedema treatment HAEGARDA, to be delivered...
- This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration to CSL Behring L.L.C., a global biotherapeutics company, to provide the Hereditary Angioedema treatment HAEGARDA. The $174,148.50 firm fixed price delivery order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration. The contract has no set-aside designation and the place of performance is CSL Behring's facility...
- This federal contract award is for the delivery of HAEGARDA, a treatment for Hereditary Angioedema, to the Department of Veterans Affairs (VA) Veterans Health Administration. The $119,814.22 firm fixed price delivery order was issued against CSL Behring LLC's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration (GSA). This contract allows the VA and other agencies to efficiently procure pharmaceutical products through task orders. The award has no...
- This is a $101,660.40 delivery order awarded by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a foreign-owned, for-profit pharmaceutical company. The order was placed under CSL Behring's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which has a ceiling value of $201,482,280 and is valid through September 2026. The delivery order is for emergency supplies and has a completion date of September 30, 2015. CSL Behring holds additional Blanket...
- This federal contract award is for a delivery order issued to CSL Behring L.L.C., doing business as CSL Behring LLC, by the Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network 22. The order, valued at $188,118.90, is for the procurement of the Hereditary Angioedema treatment drug HAEGARDA. The contract is awarded under CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration (GSA)....
- The Department of Veterans Affairs Veterans Health Administration, through its Veterans Integrated Service Network 22, awarded a $153,282.20 firm fixed-price delivery order to CSL Behring L.L.C. for the Hereditary Angioedema treatment HAEGARDA. This order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration, which allows federal agencies to efficiently procure pharmaceuticals through task orders. The contract has...
- This federal contract award to CSL Behring L.L.C., doing business as CSL Behring LLC, is for the delivery of HAEGARDA, a drug used to treat Hereditary Angioedema, to the Department of Veterans Affairs (VA) Veterans Health Administration. The $195,086.00 firm fixed price award was made through the Pharmaceuticals and Drugs Federal Supply Schedule contract managed by the General Services Administration (GSA). The contract has no set-aside designation. This award is associated with a $17.5...